Project Apollonia

Radiation Injury Solutions

Biomedical R&D as an Enabler of Human Spaceflight and Terrestrial Innovation

Project Apollonia is the research and development arm of Lambsbread. We are solutions-focused on space biology, radiation injury, and translational countermeasures. Our R&D team integrates molecular biology, radiobiology, and systems-level modeling to develop scalable, dual-use technologies, designed for astronaut health protection while directly informing terrestrial applications in oncology, diagnostics, and advanced healthcare research.

By aligning discovery science with translational and pre-commercial development, Project Apollonia supports mission-critical needs for aerospace and defense stakeholders while generating downstream value across civilian biomedical markets.

Biomedical research and development is a critical enabler of sustained human presence beyond low Earth orbit. As commercial and government spaceflight transitions from experimental missions to operational systems, protecting human health in extreme environments becomes both a biological necessity and a strategic market opportunity.

The Problem with Space

Extended human spaceflight exposes crews to a combination of hazards not encountered on Earth. These risks are well documented by NASA’s Human Research Program and the National Council on Radiation Protection and Measurements (NCRP):

• Ionizing space radiation
  • DNA damage, mutagenesis, and elevated lifetime cancer risk
  • Neuroinflammation and potential cognitive impairment
    (NASA HRP; NCRP Report No. 153)
• Immune system dysregulation
  • Suppressed immune surveillance and altered inflammatory responses
    (NASA HRP Integrated Immune Risk)
• Neurocognitive, musculoskeletal, and metabolic decline
  • Bone density loss, muscle atrophy, and neurological effects driven by microgravity
    (NASA HRP Human Health Countermeasures)
• Systems-level physiological disruption
  • Microgravity-induced changes to cardiovascular, musculoskeletal, and immune function
    (NASA Twin Study; ISS Human Research Findings)

Mitigating these risks is essential for long-duration missions to the Moon, Mars, and beyond. Critically, the same biological mechanisms underlying spaceflight injury, radiation damage, inflammatory signaling, tissue degeneration, and cancer initiation are shared with age-related diseases.

Dual-Use Impact: From Spaceflight to Earth-Based Markets

Countermeasures developed for space are not niche solutions. They directly translate into high-value applications across multiple sectors:

• Oncology and radiation medicine
  • Improved understanding of radiation injury pathways and cancer risk modulation
    (NIH/NCI radiobiology frameworks)
• Diagnostics and biodosimetry
  • Non-invasive biomarkers for radiation exposure, disease risk, and treatment response
• Remote and austere medicine
  • Monitoring and intervention technologies applicable to military, disaster, and rural healthcare
• Risk modeling and health analytics
  • Data-driven approaches relevant to insurers, government planners, and population health programs.

For government buyers, we provide mission-aligned capability development across aerospace, defense, and health agencies.

For investors, we represent capital-efficient innovation rooted in federally validated science with multiple commercialization pathways.

Project Apollonia operates at this intersection by providing radiation injury solutions while building technologies designed to scale on Earth and beyond.